In RA, the efforts should be aimed at investigating whether circulating RNASET2 can be included among surrogate biomarkers that could be used to predict RA synovial tissue phenotypes and the corresponding therapeutic response53. Here, RNASET2 is linked to rheumatoid arthritis.